Ceftazidime and Ifosfamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftazidime (ceftazidime) and Ifosfamide (ifosfamide). Common drug interactions include cardiotoxicity among females and guillain-barre syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftazidime and Ifosfamide. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

What is Ifosfamide?

Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.

On Jul, 13, 2026

73 people who take Ceftazidime and Ifosfamide together, and have interactions are studied.

Ceftazidime and Ifosfamide drug interactions.

What are the common drug interactions of Ceftazidime and Ifosfamide, by gender? *:

female:

Cardiotoxicity (damage to the heart muscle)
Drug ineffective
Septic shock (shock due to blood infection)
Neuropathy peripheral (surface nerve damage)
Paraparesis (partial paralysis of the lower limbs)
Pneumonia
Abdominal pain
Blood creatinine increased
Bone marrow disorder
Diarrhoea

male:

Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
Areflexia (absence of a reflex)
Enterobacter sepsis (sepsis due to bacteria of the family enterobacteriaceae)
Pseudomonal sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas)
Disease progression
Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Pyrexia (fever)
Rash
Febrile neutropenia (fever with reduced white blood cells)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

What are the common drug interactions of Ceftazidime and Ifosfamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Disease progression
Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Pyrexia (fever)
Rash
Febrile neutropenia (fever with reduced white blood cells)
Anxiety
Blood pressure decreased
Candidal infection (fungal infection)
Cardiomegaly (increased size of heart than normal)
Chest pain

10-19:

Agitation (state of anxiety or nervous excitement)
Body temperature increased
Confusional state
Febrile neutropenia (fever with reduced white blood cells)
Haemolytic anaemia (anaemia due to haemolysis)
Headache (pain in head)
Intravascular haemolysis (intravascular rupture of red blood cells with the release of haemoglobin and the cellular constituents into the plasma, or liquid portion of whole blood)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Mucosal inflammation (infection of mucous membrane)
Nephropathy toxic (damage to kidney due to toxins)

20-29:

Cardiotoxicity (damage to the heart muscle)
Platelet count decreased
Abdominal pain
Blood creatinine increased
Bone marrow disorder
Diarrhoea
Ejection fraction decreased (systolic heart failure)
Febrile neutropenia (fever with reduced white blood cells)
Gastric disorder (disease of stomach)
Haematemesis (vomiting of blood)

30-39:

Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
Areflexia (absence of a reflex)
Demyelinating polyneuropathy (disorder that affects the nerves outside of the brain and spinal cord (peripheral nerves))
Hypoaesthesia (reduced sense of touch or sensation)
Hypotonia (low muscle tone)
Peripheral nerve injury
Quadriplegia (a four limb paralysis)
Urinary retention (the inability to completely or partially empty the bladder)
Hodgkin's disease recurrent (cancer originating from white blood cells -recurrent)
Mucosal inflammation (infection of mucous membrane)

40-49:

Drug ineffective
Septic shock (shock due to blood infection)
Fungal infection
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Lung disorder (lung disease)
Neutropenia (an abnormally low number of neutrophils)
Skin nodule (slightly elevated lesions on or in the skin)

50-59:

Diffuse large b-cell lymphoma recurrent (recurrent cancer of b cells, a type of white blood cell)
Iris neovascularisation (a condition of the iris of the eye in which new abnormal blood vessels)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

60+:

n/a

What are the existing conditions these people have? *

Hodgkin's Lymphoma (cancer originating from white blood cells): 25 people, 34.25%
Pneumonia: 21 people, 28.77%
Hodgkin's Disease Recurrent (cancer originating from white blood cells -recurrent): 21 people, 28.77%
Metastases To Lymph Nodes (cancer spreads to lymph node): 13 people, 17.81%
Central Nervous System Lymphoma (cancer of central nervous system forms in lymph tissue): 11 people, 15.07%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 9.59%
Febrile Neutropenia (fever with reduced white blood cells): 7 people, 9.59%
Burkitt's Lymphoma (cancer of the lymphatic system): 7 people, 9.59%
Osteosarcoma (a cancerous (malignant) bone tumour): 6 people, 8.22%
Pain: 5 people, 6.85%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftazidime and Ifosfamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously